Alzheimer's and Dementia: Translational Research and Clinical Interventions
ESCI-ISI SCOPUS (2015-2025)
2352-8737
Mỹ
Cơ quản chủ quản: WILEY , John Wiley & Sons Inc.
Lĩnh vực:
Psychiatry and Mental HealthNeurology (clinical)
Phân tích ảnh hưởng
Các bài báo tiêu biểu
Inflammation as a central mechanism in Alzheimer's disease
Tập 4 Số 1 - Trang 575-590 - 2018
AbstractAlzheimer's disease (AD) is a progressive neurodegenerative disorder
that is characterized by cognitive decline and the presence of two core
pathologies, amyloid β plaques and neurofibrillary tangles. Over the last
decade, the presence of a sustained immune response in the brain has emerged as
a third core pathology in AD. The sustained activation of the brain's resident
macrophages (micro...
Alzheimer's disease drug development pipeline: 2018
Tập 4 Số 1 - Trang 195-214 - 2018
AbstractIntroductionTreatments for Alzheimer's disease (AD) are needed due to
the growing number of individuals with preclinical, prodromal, and dementia
forms of AD. Drug development for AD therapies can be examined by inspecting the
drug development pipeline as represented on
clinicaltrials.gov.MethodsClinicaltrials.gov was assessed as of January 30, 2018
to determine AD therapies represented in...
Alzheimer's disease drug development pipeline: 2017
Tập 3 Số 3 - Trang 367-384 - 2017
AbstractIntroductionThere is an urgent need to develop new treatments for
Alzheimer's disease (AD) and to understand the drug development process for new
AD therapies.MethodsWe assessed the agents in the AD pipeline as documented in
clinicaltrials.gov for phase I, phase II, and phase III, accessed
1/5/2017.ResultsThere are 105 agents in the AD treatment development pipeline,
of which 25 agents are...
Sedentary behavior as a risk factor for cognitive decline? A focus on the influence of glycemic control in brain health
Tập 3 Số 3 - Trang 291-300 - 2017
AbstractCognitive decline leading to dementia represents a global health burden.
In the absence of targeted pharmacotherapy, lifestyle approaches remain the best
option for slowing the onset of dementia. However, older adults spend very
little time doing moderate to vigorous exercise and spend a majority of time in
sedentary behavior. Sedentary behavior has been linked to poor glycemic control
and...
Amyloid‐associated increases in longitudinal report of subjective cognitive complaints
Tập 4 - Trang 444-449 - 2018
AbstractIntroductionTo investigate whether baseline subjective cognitive
complaints (SCCs) predict longitudinal decline on neuropsychological testing and
whether SCC increases longitudinally, in the setting of high levels of amyloid
burden.MethodsTwo hundred seventy‐nine clinically normal older participants
(mean age = 73.7 ± 6.1 years) from the Harvard Aging Brain Study, a cohort of
community‐dwe...
Accelerating drug development for Alzheimer's disease through the use of data standards
Tập 3 - Trang 273-283 - 2017
AbstractIntroductionThe exceedingly high rate of failed trials in Alzheimer's
disease (AD) calls for immediate attention to improve efficiencies and learning
from past, ongoing, and future trials. Accurate, highly rigorous standardized
data are at the core of meaningful scientific research. Data standards allow for
proper integration of clinical data sets and represent the essential foundation
for...
Translational inhibition of APP by Posiphen: Efficacy, pharmacodynamics, and pharmacokinetics in the APP/PS1 mouse
Tập 4 - Trang 37-45 - 2018
AbstractIntroductionTranslational inhibition of amyloid precursor protein (APP)
by Posiphen has been shown to reduce APP and its fragments in cell culture,
animal models, and mildly cognitively impaired patients, making it a promising
drug candidate for the treatment of Alzheimer's disease.MethodsWe used a mouse
model of Alzheimer's disease (APP/presenilin‐1) to examine Posiphen's efficacy,
pharma...
Potential implications of practice effects in Alzheimer's disease prevention trials
Tập 3 - Trang 531-535 - 2017
AbstractIntroductionPractice effects (PEs) present a potential confound in
clinical trials with cognitive outcomes. A single‐blind placebo run‐in design,
with repeated cognitive outcome assessments before randomization to treatment,
can minimize effects of practice on trial outcome.MethodsWe investigated the
potential implications of PEs in Alzheimer's disease prevention trials using
placebo arm d...
Social interaction and cognitive decline: Results of a 7‐year community intervention
Tập 3 - Trang 23-32 - 2017
AbstractIntroductionThere are few intervention studies that demonstrated linking
social participation to lower risk of cognitive decline. We examined
prospectively the protective effect of a community intervention program
promoting social participation on the incidence of cognitive
disability.MethodsThe baseline was established in a survey of community‐dwelling
older people aged 65 years old or mo...
The Age‐Well observational study on expert meditators in the Medit‐Ageing European project
Tập 4 - Trang 756-764 - 2018
AbstractIntroductionThe Age‐Well observational, cross‐sectional study
investigates the affective and cognitive mechanisms of meditation expertise with
behavioral, neuroimaging, sleep, and biological measures sensitive to aging and
Alzheimer's disease (AD).MethodsThirty cognitively unimpaired individuals aged
65 years or older with at least 10,000 hours of practice in mindfulness
meditation (MM) an...